Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.
The report details the trend, potential and market size of CRISPR/Cas9 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of CRISPR/Cas9market, defines the market attractiveness level of CRISPR/Cas9 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of CRISPR/Cas9 industry, describes the types of CRISPR/Cas9 market, the applications of major players and the market size, and deeply analyzes the current situation of the global CRISPR/Cas9 market and the development prospects and opportunities of CRISPR/Cas9 industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global CRISPR/Cas9 market in Chapter 13.
By Player:
Mirus Bio
GeneCopoeia
Cellecta
Synthego
Takara Bio
Thermo Fisher Scientific
GenScript
Intellia Therapeutics
Horizon Discovery Group
Caribou Biosciences
Agilent Technologies
Editas Medicine
Merck
CRISPR Therapeutics
Integrated DNA Technologies (IDT)
By Type:
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
By End-User:
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 CRISPR/Cas9 Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 CRISPR/Cas9 Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 CRISPR/Cas9 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 CRISPR/Cas9 Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise CRISPR/Cas9 Market Analysis and Outlook to 2022
-
7.1 Global CRISPR/Cas9 Consumption (2017-2022)
-
7.2 United States CRISPR/Cas9 Consumption (2017-2022)
-
7.3 Europe CRISPR/Cas9 Consumption (2017-2022)
-
7.4 China CRISPR/Cas9 Consumption (2017-2022)
-
7.5 Japan CRISPR/Cas9 Consumption (2017-2022)
-
7.6 India CRISPR/Cas9 Consumption (2017-2022)
-
7.7 South Korea CRISPR/Cas9 Consumption (2017-2022)
8 Region and Country-wise CRISPR/Cas9 Market Analysis and Outlook to 2028
-
8.1 Global CRISPR/Cas9 Consumption Forecast (2022-2028)
-
8.2 United States CRISPR/Cas9 Consumption Forecast (2022-2028)
-
8.3 Europe CRISPR/Cas9 Consumption Forecast (2022-2028)
-
8.4 China CRISPR/Cas9 Consumption Forecast (2022-2028)
-
8.5 Japan CRISPR/Cas9 Consumption Forecast (2022-2028)
-
8.6 India CRISPR/Cas9 Consumption Forecast (2022-2028)
-
8.7 South Korea CRISPR/Cas9 Consumption Forecast (2022-2028)
9 Global CRISPR/Cas9 Market Outlook by Types and Applications to 2022
-
9.1 Global CRISPR/Cas9 Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Genome Editing Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Genetic engineering Consumption and Growth Rate (2017-2022)
-
9.1.3 Global gRNA Database/Gene Librar Consumption and Growth Rate (2017-2022)
-
9.1.4 Global CRISPR Plasmid Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Human Stem Cells Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Genetically Modified Organisms/Crops Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Cell Line Engineering Consumption and Growth Rate (2017-2022)
-
9.2 Global CRISPR/Cas9 Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Biotechnology Companies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmaceutical Companies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Academic Institutes Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Research and Development Institutes Consumption and Growth Rate (2017-2022)
10 Global CRISPR/Cas9 Market Outlook by Types and Applications to 2028
-
10.1 Global CRISPR/Cas9 Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Genome Editing Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Genetic engineering Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global gRNA Database/Gene Librar Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global CRISPR Plasmid Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Human Stem Cells Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Genetically Modified Organisms/Crops Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Cell Line Engineering Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global CRISPR/Cas9 Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Academic Institutes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Research and Development Institutes Consumption Forecast and Growth Rate (2022-2028)
11 Global CRISPR/Cas9 Import and Export Analysis (Top 5 Countries)
-
11.1 Global CRISPR/Cas9 Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global CRISPR/Cas9 Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 CRISPR/Cas9 Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global CRISPR/Cas9 Market Competitive Analysis
-
14.1 Mirus Bio
-
14.1.1 Mirus Bio Company Details
-
14.1.2 Mirus Bio CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Mirus Bio CRISPR/Cas9 Product and Service
-
14.2 GeneCopoeia
-
14.2.1 GeneCopoeia Company Details
-
14.2.2 GeneCopoeia CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GeneCopoeia CRISPR/Cas9 Product and Service
-
14.3 Cellecta
-
14.3.1 Cellecta Company Details
-
14.3.2 Cellecta CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Cellecta CRISPR/Cas9 Product and Service
-
14.4 Synthego
-
14.4.1 Synthego Company Details
-
14.4.2 Synthego CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Synthego CRISPR/Cas9 Product and Service
-
14.5 Takara Bio
-
14.5.1 Takara Bio Company Details
-
14.5.2 Takara Bio CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Takara Bio CRISPR/Cas9 Product and Service
-
14.6 Thermo Fisher Scientific
-
14.6.1 Thermo Fisher Scientific Company Details
-
14.6.2 Thermo Fisher Scientific CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Thermo Fisher Scientific CRISPR/Cas9 Product and Service
-
14.7 GenScript
-
14.7.1 GenScript Company Details
-
14.7.2 GenScript CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GenScript CRISPR/Cas9 Product and Service
-
14.8 Intellia Therapeutics
-
14.8.1 Intellia Therapeutics Company Details
-
14.8.2 Intellia Therapeutics CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Intellia Therapeutics CRISPR/Cas9 Product and Service
-
14.9 Horizon Discovery Group
-
14.9.1 Horizon Discovery Group Company Details
-
14.9.2 Horizon Discovery Group CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Horizon Discovery Group CRISPR/Cas9 Product and Service
-
14.10 Caribou Biosciences
-
14.10.1 Caribou Biosciences Company Details
-
14.10.2 Caribou Biosciences CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Caribou Biosciences CRISPR/Cas9 Product and Service
-
14.11 Agilent Technologies
-
14.11.1 Agilent Technologies Company Details
-
14.11.2 Agilent Technologies CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Agilent Technologies CRISPR/Cas9 Product and Service
-
14.12 Editas Medicine
-
14.12.1 Editas Medicine Company Details
-
14.12.2 Editas Medicine CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Editas Medicine CRISPR/Cas9 Product and Service
-
14.13 Merck
-
14.13.1 Merck Company Details
-
14.13.2 Merck CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Merck CRISPR/Cas9 Product and Service
-
14.14 CRISPR Therapeutics
-
14.14.1 CRISPR Therapeutics Company Details
-
14.14.2 CRISPR Therapeutics CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 CRISPR Therapeutics CRISPR/Cas9 Product and Service
-
14.15 Integrated DNA Technologies (IDT)
-
14.15.1 Integrated DNA Technologies (IDT) Company Details
-
14.15.2 Integrated DNA Technologies (IDT) CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Integrated DNA Technologies (IDT) CRISPR/Cas9 Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of CRISPR/Cas9
-
Figure CRISPR/Cas9 Picture
-
Table Global CRISPR/Cas9 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global CRISPR/Cas9 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global CRISPR/Cas9 Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global CRISPR/Cas9 Consumption by Country (2017-2022)
-
Figure United States CRISPR/Cas9 Consumption and Growth Rate (2017-2022)
-
Table Europe CRISPR/Cas9 Consumption and Growth Rate (2017-2022)
-
Figure China CRISPR/Cas9 Consumption and Growth Rate (2017-2022)
-
Figure Japan CRISPR/Cas9 Consumption and Growth Rate (2017-2022)
-
Figure India CRISPR/Cas9 Consumption and Growth Rate (2017-2022)
-
Figure South Korea CRISPR/Cas9 Consumption and Growth Rate (2017-2022)
-
Figure Global CRISPR/Cas9 Consumption Forecast by Country (2022-2028)
-
Figure United States CRISPR/Cas9 Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe CRISPR/Cas9 Consumption Forecast and Growth Rate (2022-2028)
-
Figure China CRISPR/Cas9 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan CRISPR/Cas9 Consumption Forecast and Growth Rate (2022-2028)
-
Figure India CRISPR/Cas9 Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea CRISPR/Cas9 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genome Editing Consumption and Growth Rate (2017-2022)
-
Figure Global Genetic engineering Consumption and Growth Rate (2017-2022)
-
Figure Global gRNA Database/Gene Librar Consumption and Growth Rate (2017-2022)
-
Figure Global CRISPR Plasmid Consumption and Growth Rate (2017-2022)
-
Figure Global Human Stem Cells Consumption and Growth Rate (2017-2022)
-
Figure Global Genetically Modified Organisms/Crops Consumption and Growth Rate (2017-2022)
-
Figure Global Cell Line Engineering Consumption and Growth Rate (2017-2022)
-
Figure Global Biotechnology Companies Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical Companies Consumption and Growth Rate (2017-2022)
-
Figure Global Academic Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Research and Development Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Genome Editing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genetic engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global gRNA Database/Gene Librar Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CRISPR Plasmid Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Human Stem Cells Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genetically Modified Organisms/Crops Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cell Line Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Academic Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research and Development Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Table Global CRISPR/Cas9 Import by Region (Top 5 Countries) (2017-2028)
-
Table Global CRISPR/Cas9 Export by Region (Top 5 Countries) (2017-2028)
-
Table Mirus Bio (Foundation Year, Company Profile and etc.)
-
Table Mirus Bio CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mirus Bio CRISPR/Cas9 Product and Service
-
Table GeneCopoeia (Foundation Year, Company Profile and etc.)
-
Table GeneCopoeia CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
Table GeneCopoeia CRISPR/Cas9 Product and Service
-
Table Cellecta (Foundation Year, Company Profile and etc.)
-
Table Cellecta CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cellecta CRISPR/Cas9 Product and Service
-
Table Synthego (Foundation Year, Company Profile and etc.)
-
Table Synthego CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Synthego CRISPR/Cas9 Product and Service
-
Table Takara Bio (Foundation Year, Company Profile and etc.)
-
Table Takara Bio CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takara Bio CRISPR/Cas9 Product and Service
-
Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)
-
Table Thermo Fisher Scientific CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific CRISPR/Cas9 Product and Service
-
Table GenScript (Foundation Year, Company Profile and etc.)
-
Table GenScript CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
Table GenScript CRISPR/Cas9 Product and Service
-
Table Intellia Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Intellia Therapeutics CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intellia Therapeutics CRISPR/Cas9 Product and Service
-
Table Horizon Discovery Group (Foundation Year, Company Profile and etc.)
-
Table Horizon Discovery Group CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Horizon Discovery Group CRISPR/Cas9 Product and Service
-
Table Caribou Biosciences (Foundation Year, Company Profile and etc.)
-
Table Caribou Biosciences CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Caribou Biosciences CRISPR/Cas9 Product and Service
-
Table Agilent Technologies (Foundation Year, Company Profile and etc.)
-
Table Agilent Technologies CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agilent Technologies CRISPR/Cas9 Product and Service
-
Table Editas Medicine (Foundation Year, Company Profile and etc.)
-
Table Editas Medicine CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Editas Medicine CRISPR/Cas9 Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck CRISPR/Cas9 Product and Service
-
Table CRISPR Therapeutics (Foundation Year, Company Profile and etc.)
-
Table CRISPR Therapeutics CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
Table CRISPR Therapeutics CRISPR/Cas9 Product and Service
-
Table Integrated DNA Technologies (IDT) (Foundation Year, Company Profile and etc.)
-
Table Integrated DNA Technologies (IDT) CRISPR/Cas9 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Integrated DNA Technologies (IDT) CRISPR/Cas9 Product and Service
-
